NGM NASDAQ
NGM Biopharmaceuticals, Inc.
1W: -1.3%
1M: +0.7%
3M: +14.9%
1Y: -60.8%
3Y: -94.5%
5Y: -89.5%
$1.54
Last traded 2024-04-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$4M
Revenue
-92.0% YoY
$-140M
Net Income
+12.1% YoY
$-133M
Free Cash Flow
+8.8% YoY
-213.9%
Gross Margin
-17977.6%
Op. Margin
-16769.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-68.5%
ROA-58.7%
ROIC-8229.4%
Valuation
P/E-0.9
P/B0.9
EV/EBITDA0.5
Leverage
Debt/Equity0.00
Current Ratio7.79
Interest Cov.-38.0x
Quality Scores
Piotroski F3/9
Altman Z-4.79
Beneish M-19.90